|
|
|
|
|
Inactive Indication- |
Drug Highest PhaseApproved |
First Approval Ctry. / Loc.China |
First Approval Date01 Jan 1981 |
100 Clinical Results associated with Hangzhou East Pharmaceutical Co., Ltd.
0 Patents (Medical) associated with Hangzhou East Pharmaceutical Co., Ltd.
100 Deals associated with Hangzhou East Pharmaceutical Co., Ltd.
100 Translational Medicine associated with Hangzhou East Pharmaceutical Co., Ltd.